Description
Tesamorelin-is a GHRH that has FDA approval since 2010 to treat visceral fat. It is currently being studied for the regeneration of of peripheral nerve damage after injury.
Tesamorelin-is a GHRH that has FDA approval since 2010 to treat visceral fat. It is currently being studied for the regeneration of of peripheral nerve damage after injury.
| Weight | 4 lbs |
|---|---|
| Dimensions | 9 × 5 × 0.75 in |
Reviews
There are no reviews yet.